Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Sales | 4,595 | 3,055 | 12,068 | 2,857 | 941 |
| Cost of Goods | 3,724 | 3,361 | 17,081 | 2,974 | 0 |
| Gross Profit | 2 | -1,009 | -5,522 | -543 | 350 |
| Operating Expenses | 1,792 | 1,238 | -9,761 | 1,634 | 8,774 |
| Operating Income | -197 | -1,183 | 4,829 | -777 | -7,833 |
| Interest Expense | 2 | 3 | 4 | 5 | 7 |
| Other Income | -1 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -200 | -1,186 | 4,825 | -783 | -7,840 |
| Net Income Continuous | -200 | -1,186 | 4,825 | -783 | -7,840 |
| Net Income | $-200 | $-1,186 | $4,825 | $-783 | $-7,840 |
| EPS Basic Total Ops | 0.00 | -0.02 | 0.09 | -0.02 | -0.16 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | 0.09 | -0.02 | -0.15 |
| EPS Diluted Total Ops | 0.00 | -0.02 | 0.09 | -0.02 | -0.16 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | 0.09 | -0.02 | -0.15 |
| EBITDA(a) | $-197 | $-1,183 | $4,829 | $-777 | $-7,833 |